KR880013927A - 피리미딘 유도체 - Google Patents
피리미딘 유도체 Download PDFInfo
- Publication number
- KR880013927A KR880013927A KR1019880006017A KR880006017A KR880013927A KR 880013927 A KR880013927 A KR 880013927A KR 1019880006017 A KR1019880006017 A KR 1019880006017A KR 880006017 A KR880006017 A KR 880006017A KR 880013927 A KR880013927 A KR 880013927A
- Authority
- KR
- South Korea
- Prior art keywords
- infection
- formula
- hydroxy
- compound
- pyrimidine derivative
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Communicable Diseases (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- Oncology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Abstract
내용 없음
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
Claims (8)
- 일반식(Ⅰ)의 화합물, 그의 아미드 및 시프 염기.상기식에서, R1은 하이드록시 또는 에스테르화 하이드록시이다.
- 1-(2',3'-디데옥시-2'-플루오로-β-D-아라비노푸라노실)-시톡신.
- 제1항 또는 제2항에 있어서, 치료학적 활성물질, 특히 바이러스성 감염, 특히 HIV감염과같은 리트로바이러스성 감염의 치료 또는 예방에 사용하기 위한 피리미딘 유도체.
- (a) 일반식(Ⅱ)의 화합물로부터 3'-하이드록시 그룹을 제거하고, 경우에 따라, 수득된 생성물중 에스테르화 하이드로기 그룹 R10을 하이드록시 그룹으로 전환 시키거나, (b) R1이 에스테르화 하이드록시인 일반식(Ⅰ)의 화합물을 제조하기 위해, R1이 하이드록시인 일반식(Ⅰ)의 화합물을 에스테르화 시키거나, 또는 (c) 일반식(Ⅰ)의 화합물을 아미드 또는 시프 염기를 제조하기 위해, 일반식(Ⅰ)의 화합물을 아미드 또는 시프 염기로 전환시킴을 특징으로 하여 제1항에 청구된 피리미딘 유도체를 제조하는 방법.상기식에서, R10은 에스테르롸 하이드록시 그룹이다.
- 제1항 또는 제2항에서 청구한 피리미딘 유도체 및 상존 가능한 약제학적 담체 물질을 함유하는, 바이러스성 감염, 특히 HIV감염과 같은 리트로바이러스성 감염의 치료 또는 예방을 위한 약제.
- 질병의 치료 또는 예방, 특히 바이러스성 감염, 트히 HIV감염과 같은 리트로바이러스성 감염의 치료 또는 예방을 위한 제1항 또는 제2항에서 청구한 피리미딘 유도체의 용도.
- 바이러스성 감염, 특히 HIV감염과 같은 리트로바이러스성 감염의 치료 또는 예방을 목적으로 하는 약제를 제조하기 위한, 제1항 또는 제2항에 청구한 피리미딘 유도체의 용도.
- 본 명세서, 특히 실시예에 기술된 바와같은 설명.※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB8712115 | 1987-05-22 | ||
GB878712115A GB8712115D0 (en) | 1987-05-22 | 1987-05-22 | Pyrimidine derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
KR880013927A true KR880013927A (ko) | 1988-12-22 |
Family
ID=10617762
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019880006017A KR880013927A (ko) | 1987-05-22 | 1988-05-21 | 피리미딘 유도체 |
Country Status (19)
Country | Link |
---|---|
EP (1) | EP0292023A3 (ko) |
JP (1) | JPS63303992A (ko) |
KR (1) | KR880013927A (ko) |
CN (1) | CN88103089A (ko) |
AU (1) | AU602083B2 (ko) |
DK (1) | DK165985C (ko) |
FI (1) | FI882303A (ko) |
GB (1) | GB8712115D0 (ko) |
HU (1) | HU199868B (ko) |
IL (1) | IL86394A0 (ko) |
IS (1) | IS3344A7 (ko) |
MC (1) | MC1934A1 (ko) |
MX (1) | MX11493A (ko) |
NO (1) | NO171065C (ko) |
NZ (1) | NZ224638A (ko) |
PH (1) | PH26909A (ko) |
PT (1) | PT87550B (ko) |
YU (1) | YU46860B (ko) |
ZA (1) | ZA883447B (ko) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1340645C (en) * | 1987-04-17 | 1999-07-13 | Victor E. Marquez | Acid stable dideoxynucleosides active against the cytopathic effects of human immunodeficiency virus |
US4908440A (en) * | 1987-11-12 | 1990-03-13 | Bristol Myers Company | 2',3'-dideoxy-2'-fluoroarabinopyrimidine nucleosides |
GR1000618B (el) * | 1989-03-17 | 1992-08-31 | Oncogen | Μεθοδος αναστολης hiv χρησιμοποιωντας συνεργιστικους συνδυασμους νουκλεοσιδικων παραγωγων. |
EP0500610A1 (en) * | 1989-11-06 | 1992-09-02 | Nycomed Imaging As | Nucleoside derivatives |
AT400953B (de) * | 1994-08-25 | 1996-05-28 | Joern Saischek | Pentofuranosid-derivate, deren herstellung und verwendung |
KR100954390B1 (ko) | 1998-02-25 | 2010-04-26 | 에모리 유니버시티 | 2'-플루오로뉴클레오사이드 |
DK1411954T3 (da) | 2000-10-18 | 2011-03-14 | Pharmasset Inc | Modificerede nukleosider til behandling af virusinfektioner og abnorm cellulær proliferation |
EP1478322A4 (en) | 2001-06-22 | 2007-08-08 | Pharmasset Ltd | Beta 2'-OR 3'-HALONUCLEOSIDE |
DE602005015466D1 (de) | 2004-08-23 | 2009-08-27 | Hoffmann La Roche | Antivirale 4'-azidonucleoside |
US8895531B2 (en) | 2006-03-23 | 2014-11-25 | Rfs Pharma Llc | 2′-fluoronucleoside phosphonates as antiviral agents |
ATE493428T1 (de) | 2006-10-10 | 2011-01-15 | Medivir Ab | Hcv-nukleosidinhibitor |
-
1987
- 1987-05-22 GB GB878712115A patent/GB8712115D0/en active Pending
-
1988
- 1988-04-26 DK DK227388A patent/DK165985C/da active
- 1988-05-13 YU YU93288A patent/YU46860B/sh unknown
- 1988-05-16 IL IL86394A patent/IL86394A0/xx unknown
- 1988-05-16 NZ NZ224638A patent/NZ224638A/en unknown
- 1988-05-16 MX MX1149388A patent/MX11493A/es unknown
- 1988-05-16 ZA ZA883447A patent/ZA883447B/xx unknown
- 1988-05-17 FI FI882303A patent/FI882303A/fi not_active Application Discontinuation
- 1988-05-17 AU AU16317/88A patent/AU602083B2/en not_active Ceased
- 1988-05-18 PH PH36945A patent/PH26909A/en unknown
- 1988-05-18 HU HU882469A patent/HU199868B/hu not_active IP Right Cessation
- 1988-05-19 MC MC881980A patent/MC1934A1/xx unknown
- 1988-05-19 IS IS3344A patent/IS3344A7/is unknown
- 1988-05-19 JP JP63120806A patent/JPS63303992A/ja active Pending
- 1988-05-20 NO NO882233A patent/NO171065C/no unknown
- 1988-05-20 PT PT87550A patent/PT87550B/pt not_active IP Right Cessation
- 1988-05-21 CN CN198888103089A patent/CN88103089A/zh active Pending
- 1988-05-21 KR KR1019880006017A patent/KR880013927A/ko not_active Application Discontinuation
- 1988-05-24 EP EP88108271A patent/EP0292023A3/de not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
PT87550B (pt) | 1992-09-30 |
PH26909A (en) | 1992-12-03 |
DK227388D0 (da) | 1988-04-26 |
MC1934A1 (fr) | 1989-05-19 |
PT87550A (pt) | 1989-05-31 |
FI882303A (fi) | 1988-11-23 |
IS3344A7 (is) | 1988-11-23 |
MX11493A (es) | 1993-09-01 |
DK165985C (da) | 1993-11-08 |
FI882303A0 (fi) | 1988-05-17 |
DK227388A (da) | 1988-11-23 |
CN88103089A (zh) | 1988-12-07 |
YU46860B (sh) | 1994-06-24 |
DK165985B (da) | 1993-02-22 |
NZ224638A (en) | 1990-04-26 |
JPS63303992A (ja) | 1988-12-12 |
NO171065B (no) | 1992-10-12 |
AU1631788A (en) | 1988-11-24 |
EP0292023A3 (de) | 1989-06-14 |
NO882233D0 (no) | 1988-05-20 |
NO171065C (no) | 1993-01-20 |
HU199868B (en) | 1990-03-28 |
AU602083B2 (en) | 1990-09-27 |
EP0292023A2 (de) | 1988-11-23 |
ZA883447B (en) | 1988-11-22 |
GB8712115D0 (en) | 1987-06-24 |
NO882233L (no) | 1988-11-23 |
IL86394A0 (en) | 1988-11-15 |
HUT47127A (en) | 1989-01-30 |
YU93288A (en) | 1990-04-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR950017957A (ko) | 3, 4, 4-삼치환-피페리디닐-n-알킬카르복실레이트의 제법 및 중간체 | |
KR890003761A (ko) | 치료학적 아시클릭 뉴클레오시드 | |
MA20322A1 (fr) | Nouveaux derives de n-(4-piperidinyl)-bicyclo condenses 2-imidozolamine et procede pour leur preparation | |
UA41446C2 (uk) | Застосування фумагілолу та його похідних для одержання ліків, призначених для боротьби з кишковими інфекціями, та фармацевтична композиція на їх основі | |
ES2083668T3 (es) | Combinaciones antiviricas que contienen analogos de nucleosidos. | |
ATE122654T1 (de) | Behandlung von hiv-infizierungen und nützliche verbindungen dafür. | |
KR880013927A (ko) | 피리미딘 유도체 | |
KR890003382A (ko) | 항 비루스성 화합물 | |
BE1003341A4 (fr) | Hydrochloride monohydrate de l'ester ethylique de l'acide 6-brome-5-hydroxy-4-dimethylaminomethyl-1-methyl-2-phenylthiomethylindole-3-carbonique, procede de son obtention et medicament antivirus, d'effet inducteur d'interferon et immunomodulant a base de cette substance. | |
DE69333723D1 (de) | Pharmazeutische zubereitung auf der basis von rhamnolipid gegen dermatologische erkrankungen | |
TNSN90021A1 (fr) | Procede de preparation de tetrahydroimidazo (1,4) benzodiazepin -2- thiones antivirales | |
KR880007080A (ko) | 제약학적 생성물 | |
KR890008136A (ko) | 항균성 9-데옥소-9a-알릴 및 프로파길-9a-아자-9a-호모에리트로 마이신 A 유도체 | |
IL93594A0 (en) | Pharmaceutical compositions containing an imidazopyrimidone derivative | |
DE68929321D1 (de) | Therapeutische Anwendungen von 2',5'-Oligoadenylat-Derivaten | |
KR920017660A (ko) | 의약품 | |
KR890009901A (ko) | 3-히드록시-2-(4-메톡시페닐)-5-(2-메틸아미노에틸)-2,3-디히드로-5h-1,5- 벤조티아제핀-4-온 유도체, 그의 제조 및 치료에의 이용 | |
KR880013938A (ko) | 활성 화합물들 | |
KR890017363A (ko) | 스트로빌루린 유도체, 이들의 제법 및 용도 | |
KR890701582A (ko) | 치료용 뉴클레오사이드 | |
RU94046312A (ru) | Применение биологически активных уреидопроизводных для лечения индуцируемых лентивирусами заболеваний, продукты, содержащие уреидопроизводные | |
KR890006666A (ko) | 퓨린 유도체 | |
KR920008035A (ko) | 타이로신 유도체 및 그 제조방법 | |
KR930005621A (ko) | 고혈압 치료용 제약 조성물 | |
KR880009644A (ko) | 궤양성 대장질환 치료용 약한 조성물 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WITN | Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid |